SBC Medical to Announce 1Q 2026 Financial Results
Rhea-AI Summary
SBC Medical (Nasdaq: SBC) will release its first-quarter 2026 financial results for the period ended March 31, 2026, before U.S. market open on May 14, 2026.
Management will host an earnings conference call on May 14, 2026, at 8:30 a.m. Eastern Time with a Q&A session; the release, slides, and archived webcast will be available on the company investor relations website.
Positive
- None.
Negative
- None.
News Market Reaction – SBC
In the May 1 session, SBC gained 0.30%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Mar 13 | Earnings date notice | Positive | +0.8% | Announcement of Q4 and full-year 2025 earnings release date and call details. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Prior earnings-date scheduling news for SBC prompted only a modest positive move, indicating historically limited price impact from this type of announcement.
Over the past months, SBC reported Q4:25 results with revenue of about $39.6M and a reiterated research price target of $9.00. The company also executed a secondary public offering by a major shareholder at $3.25 per share, which coincided with short-term price declines. The last earnings-date announcement on Mar 13, 2026 led to a roughly 0.85% positive move, suggesting scheduling releases alone have had modest impact compared with offering-related headlines.
Key Terms
investor relations financial
webcast technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
IRVINE, Calif., May 01, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced it will release its financial results for the first quarter ended March 31, 2026, before U.S. market open on May 14, 2026.
Management will host an earnings conference call on May 14, 2026, at 8:30 a.m. Eastern Time. A question‑and‑answer session with analysts and investors will follow the prepared remarks.
Please register in advance for the conference using the link provided below.
https://zoom.us/webinar/register/WN_6RZgrwsUREiRpAmBBGTikA
Additionally, the earnings release, accompanying slides, and an archived webcast of this conference call will be available at the Company’s Investor Relations website at https://ir.sbc-holdings.com/
About SBC Medical Group Holdings Incorporated
SBC Medical Group Holdings Incorporated is a Medical Services Organization providing management support across a wide range of healthcare fields, including advanced aesthetic healthcare, dermatology, orthopedics, fertility treatment, gynecology, dentistry, alopecia treatment (AGA), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the Company was listed on Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000® Index, a broad benchmark of the U.S. equity market. Guided by its Group Purpose “Contributing to the well-being of people around the world through medical innovation,” SBC Medical Group Holdings Incorporated continues to provide safe, trusted, and high-quality medical services while further strengthening its international reputation for quality and trust in medical care.
For more information, visit https://sbc-holdings.com
For more insights and updates from SBC Medical, follow us on LinkedIn.
Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company’s beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company’s control. These forward-looking statements reflect the Company’s current views with respect to, among other things, the Company’s product launch plans and strategies; growth in revenue and earnings; and business prospects. In some cases, forward-looking statements can be identified by the use of words such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” “targets” or “hopes” or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management’s current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading “Risk Factors” and elsewhere in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”), which are accessible on the SEC’s website at www.sec.gov.
Contacts
SBC Medical Group Holdings Incorporated
Hikaru Fukui / Head of IR Department; E-mail: ir@sbc-holdings.com
